San Diego, CA, Aug. 4 (Korea Bizwire) – Creo, an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the successful completion of its first commercial fermentation run at 28,000 L scale with performance that exceeded the Company’s expectations. The fermentation took place at Creo’s manufacturing partner’s US FDA registered food-grade cGMP [...]
San Diego, CA, June 30 (Korea Bizwire) – Creo, an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the issuance of an important foundational patent in its IP portfolio. The United States Patent and Trademark Office issued patent no 11046978, “Microbial Synthesis of Isoprenoids and Derivatives”. This patent covers a [...]
VEJLE, Denmark, Jan. 7 (Korea Bizwire) — Claudio Bidco A/S (the “Parent Company”), the parent company of Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of MedCan Pharma A/S (“MedCan Pharma”), a research organisation focusing on developing innovative products containing cannabinoids with a primary focus on the fast-growing market for medicated cannabis. [...]